(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ADJUPANRIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ADJUPANRIX

ST13

US500000098151423

Class

5

Filing

98151423

Registration

7429357

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

06/25/2024

Trademark type

Word

Nice classes

5

Filing date

08/25/2023

Registration date

06/25/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/25/2024

Last transaction

06/25/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Rixensart, BE

Examiner

THOMPSON, HEATHER

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

GlaxoSmithKline Biologicals SA

Representatives

Christopher M. Hanes GSK

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Vaccines

Publications

History of USPTO decisions and trademark events.

15 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/25/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

06/25/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/09/2024

PUBO

PUBLISHED FOR OPPOSITION

04/09/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/20/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/04/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/01/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/01/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/01/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/31/2024

GNRT

NON-FINAL ACTION E-MAILED

01/31/2024

CNRT

NON-FINAL ACTION WRITTEN

01/31/2024

DOCK

ASSIGNED TO EXAMINER

01/31/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/20/2023

NWAP

NEW APPLICATION ENTERED

08/29/2023

Continuous trademark protection

Get notified about every new filing that threatens ADJUPANRIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.